Leptin Trial "Small Bowel Diversion" (NCT06374368) Terminated

A clinical trial involving leptin was updated on November 6, 2026, with a status change to terminated. The trial, registered as NCT06374368 and titled "Small Bowel Diversion," is listed with a phase designation of not applicable. According to the ClinicalTrials.gov record, the study status is now terminated. No reason for the termination is provided in the available event data. No results, efficacy outcomes, or safety findings are included in this update. The record does not specify how many participants were enrolled or at what stage the study ended. Leptin remains an approved compound, and this update pertains only to the status of this specific registered trial. Readers should note that a termination listing reflects the trial's administrative status as recorded and does not by itself indicate the reason, outcome, or any safety signal associated with leptin. Further details, if released, would typically appear in subsequent updates to the same ClinicalTrials.gov record. For more background on leptin, including its approved uses and general profile, see the compound overview.